Chromocell Therapeutics (Chromocell Therapeutics) Other Current Payables : $0.00 Mil (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Chromocell Therapeutics Other Current Payables?

Chromocell Therapeutics's Other Current Payables for the quarter that ended in Mar. 2024 was $0.00 Mil.

Chromocell Therapeutics's quarterly Other Current Payables declined from Sep. 2023 ($0.01 Mil) to Dec. 2023 ($0.00 Mil) and declined from Dec. 2023 ($0.00 Mil) to Mar. 2024 ($0.00 Mil).

Chromocell Therapeutics's annual Other Current Payables increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.00 Mil) but then stayed the same from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.00 Mil).

Chromocell Therapeutics Other Current Payables Historical Data

The historical data trend for Chromocell Therapeutics's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chromocell Therapeutics Other Current Payables Chart

Chromocell Therapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Other Current Payables

Chromocell Therapeutics Quarterly Data
	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Current Payables	Get a 7-Day Free Trial							0.01	0.01	0.01	-	-

Chromocell Therapeutics Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Chromocell Therapeutics Other Current Payables Related Terms

Thank you for viewing the detailed overview of Chromocell Therapeutics's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

Chromocell Therapeutics (Chromocell Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chromocell Therapeutics Corp (AMEX:CHRO) » Definitions » Other Current Payables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Chromocell Therapeutics Corp is a clinical-stage biotech company focused on developing and commercializing new therapeutics to alleviate pain. Its clinical focus is to selectively target the sodium ion-channel known as "NaV1.7", as well as other receptors in the NaV family. NaV1.7 has been genetically validated as a pain receptor in human physiology.